Simvastatin Reduces Vasospasm After Aneurysmal Subarachnoid Hemorrhage

Top Cited Papers
Open Access
Abstract
Background and Purpose— Cerebral vasospasm remains a major source of morbidity after aneurysmal subarachnoid hemorrhage (SAH). We demonstrate that simvastatin reduces serum markers of brain injury and attenuates vasospasm after SAH.